The estimated Net Worth of Jonathan Robert Hunt is at least $73.6 mil dollars as of 1 December 2022. Mr. Hunt owns over 85,404 units of Perspective Therapeutics Inc stock worth over $73,617 and over the last 17 years he sold ISR stock worth over $0. In addition, he makes $0 as Chief Financial Officer e Co-Principal Financial Officer at Perspective Therapeutics Inc.
Jonathan has made over 3 trades of the Perspective Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 85,404 units of ISR stock worth $32,454 on 1 December 2022.
The largest trade he's ever made was buying 85,404 units of Perspective Therapeutics Inc stock on 1 December 2022 worth over $32,454. On average, Jonathan trades about 19,171 units every 77 days since 2007. As of 1 December 2022 he still owns at least 191,710 units of Perspective Therapeutics Inc stock.
You can see the complete history of Mr. Hunt stock trades at the bottom of the page.
Jonathan Robert Hunt serves as Chief Financial Officer, Co-Principal Financial Officer of the Company. Jonathan Hunt - Mr. Hunt was appointed as Chief Financial Officer of the Company on December 3, 2018. On February 12, 2019, Mr. Hunt was appointed as Co-Principal Financial Officer. Before joining the Company, Mr. Hunt was Chief Financial Officer at Vivid Learning Systems, an online safety training company, from 2009 to 2018, where he had a central role in its turnaround, including growing revenues and implementing financial policy and process changes that ultimately resulted in the successful sale of the business. Mr. Hunt previously served as Chief Financial Officer of the Company from 2006 to 2009. Prior to that, Mr. Hunt worked at Hypercom Corporation, a global provider of electronic payment solutions and manufacturer of credit card terminals, where he served as Assistant Corporate Controller from 2005 to 2006. Mr. Hunt holds a Bachelor of Science, Accountancy, and a Masters of Accountancy degree from Brigham Young University.
Jonathan Hunt is 52, he's been the Chief Financial Officer e Co-Principal Financial Officer of Perspective Therapeutics Inc since 2019. There are 8 older and 8 younger executives at Perspective Therapeutics Inc. The oldest executive at Perspective Therapeutics Inc is Philip Vitale, 73, who is the Independent Director.
Jonathan's mailing address filed with the SEC is 350 HILLS STREET, SUITE 106, , RICHLAND, WA, 99354.
Over the last 18 years, insiders at Perspective Therapeutics Inc have traded over $0 worth of Perspective Therapeutics Inc stock and bought 1,651,741 units worth $855,397 . The most active insiders traders include Lori A Woods, Thomas C Lavoy, eDwight William Babcock. On average, Perspective Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $14,501. The most recent stock trade was executed by Lori A Woods on 13 April 2023, trading 187,500 units of ISR stock currently worth $114,375.
Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium Blu brachytherapy seeds, which are expanding brachytherapy treatment options throughout the body.
Perspective Therapeutics Inc executives and other stock owners filed with the SEC include: